Sign in
4

Changes in Ownership

CNS Pharmaceuticals, Inc. Filed Acc 0001683168-21-006141

Chief Financial Officer bought 5,000 shares at $0.94 ($4,702)

From the SEC's structured data for this filing

Trades in this filing

Downs Christopher · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-12-06 Purchase : show line 1 in the form +5,000 $0.94 $4,702 151,500 D
Open-market purchases · 5,000 sh · avg $0.94 · $4,702
Loading xslF345X03/ownership.xml…